Download Citation
Article Source:
MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells
Ebert K,
Mattes J,
Kunzke T,
Zwingenberger G,
Luber B
(2019)
MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells.
PLOS ONE 14(9): e0223225.
https://doi.org/10.1371/journal.pone.0223225